Afshar K - Search Results

1

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.

Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Among authors: afshar k. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.

2

Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.

Garcia-Pavia P, Lakdawala NK, Sinagra G, Ripoll-Vera T, Afshar K, Priori SG, Ware JS, Owens A, Li H, Angeli FS, Elliott P, MacRae CA, Judge DP. Garcia-Pavia P, et al. Among authors: afshar k. ESC Heart Fail. 2024 Aug 15. doi: 10.1002/ehf2.14955. Online ahead of print. ESC Heart Fail. 2024. PMID: 39145700 Free article.

3

Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy.

Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J. Daud A, et al. Among authors: afshar k. Circ Heart Fail. 2018 Aug;11(8):e004759. doi: 10.1161/CIRCHEARTFAILURE.117.004759. Circ Heart Fail. 2018. PMID: 30354559

4

Ultraviolet Radiation Affects Thoratec HeartMate II Driveline Mechanical Properties: A Pilot Experiment.

Evans AC, Wright GA, McCandless SP, Stoker S, Miller D, Reid BB, Horne BD, Afshar K, Kfoury AG. Evans AC, et al. Among authors: afshar k. ASAIO J. 2015 Nov-Dec;61(6):731-3. doi: 10.1097/MAT.0000000000000260. ASAIO J. 2015. PMID: 26102175

5

Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.

Kfoury AG, Miller DV, Snow GL, Afshar K, Stehlik J, Drakos SG, Budge D, Fang JC, Revelo MP, Alharethi RA, Gilbert EM, Caine WT, McKellar S, Molina KM, Hammond MEH. Kfoury AG, et al. Among authors: afshar k. J Heart Lung Transplant. 2016 Mar;35(3):335-341. doi: 10.1016/j.healun.2015.10.016. Epub 2015 Oct 23. J Heart Lung Transplant. 2016. PMID: 26586489

6

Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones.

Johnson AK, McCandless SP, Alharethi R, Caine WT, Budge D, Wright GA, Rauf A, Miller A, Stoker S, Smith H, Afshar K, Reid BB, Rasmusson BY, Kfoury AG. Johnson AK, et al. Among authors: afshar k. Clin Transplant. 2016 Mar;30(3):195-201. doi: 10.1111/ctr.12670. Epub 2016 Feb 6. Clin Transplant. 2016. PMID: 26589376

7

Discovery of TITIN Gene Truncating Variant Mutations and 5-Year Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.

Anderson JL, Christensen GB, Escobar H, Horne BD, Knight S, Jacobs V, Afshar K, Hebl VB, Muhlestein JB, Knowlton KU, Carlquist JF, Nadauld LD. Anderson JL, et al. Among authors: afshar k. Am J Cardiol. 2020 Dec 15;137:97-102. doi: 10.1016/j.amjcard.2020.09.026. Epub 2020 Sep 28. Am J Cardiol. 2020. PMID: 32998006

8

Mechanisms of Improved Mortality Following Ablation: Does Ablation Restore Beta-Blocker Benefit in Atrial Fibrillation/Heart Failure?

Bunch TJ, May HT, Afshar K, Alharethi R, Day JD. Bunch TJ, et al. Among authors: afshar k. Cardiol Clin. 2019 May;37(2):177-183. doi: 10.1016/j.ccl.2019.01.011. Epub 2019 Feb 27. Cardiol Clin. 2019. PMID: 30926019 Review.

9

Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies.

Afshar K, Bunch TJ. Afshar K, et al. Curr Treat Options Cardiovasc Med. 2017 Sep 14;19(10):75. doi: 10.1007/s11936-017-0574-y. Curr Treat Options Cardiovasc Med. 2017. PMID: 28913817 Review.

10

Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis.

St Pierre L, Berhan A, Sung EK, Alvarez JR, Wang H, Ji Y, Liu Y, Yu H, Meier A, Afshar K, Golts EM, Lin GY, Castaldi A, Calvert BA, Ryan A, Zhou B, Offringa IA, Marconett CN, Borok Z. St Pierre L, et al. Among authors: afshar k. Biochim Biophys Acta Mol Basis Dis. 2024 Nov 13:167572. doi: 10.1016/j.bbadis.2024.167572. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39547519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters